Purchase Order 75N98026P00379

<p>The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc. on September 25, 2014, with a ceiling value of $494,513.97, for preclinical development support including expression and production of HIV-1 envelope protein.</p> <p>Place of performance is Rockville, MD. The delivery order is priced on a cost-plus-fixed-fee basis with an ultimate completion date of September 25, 2017. No set-aside was used.</p>

The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc. on November 30, 2016, under the HIV Microbicides and Biomedical Prevention 2016–2021 IDIQ, with a ceiling value of $530,845.56 for material receipt, storage, shipping, and inventory services. Place of performance is Rockville, Maryland. The order was priced on a cost-plus-fixed-fee basis with an ultimate completion date of July 14, 2023. No set-aside was used.

<p>The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc. on May 2, 2014, for NIAID preclinical development support — SVEU database rewrite, with a ceiling value of $526,079.33.</p> <p>The order is priced on a cost-plus-fixed-fee basis. Place of performance is Rockville, MD. The ultimate completion date is April 30, 2016. No set-aside was used for this delivery order.</p>

The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc. on September 1, 2019, with a ceiling value of $1,261,199.23 under the HIV Microbicides and Biomedical Prevention 2016–2021 parent IDIQ for statistical and pharmacometric modeling support for HIV nonvaccine biomedical prevention product development. Place of performance is Rockville, MD. The order is priced on a cost-plus-fixed-fee basis and completed on August 31, 2023....

The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc., valued at $537,740.10, on August 9, 2018, under the HIV Microbicides and Biomedical Prevention 2016–2021 IDIQ for ethnographic research related to enhancement of study drug adherence and uptake in HIV prevention trials. Place of performance is Rockville, MD. The order is priced on a cost-plus-fixed-fee basis with a ceiling value of $537,740.10 and ultimate completion...

The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc., on July 27, 2017, under the HIV Microbicides and Biomedical Prevention 2016–2021 IDIQ, with a ceiling value of $20,639.16. The order covers support for regulatory expertise in the development of live biotherapeutic agents and comprehensive resources for HIV microbicides and biomedical prevention. Place of performance is Rockville, Maryland. The ultimate completion date...

<p>The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc. on September 26, 2014, with a ceiling value of $3,866,533.19 for preclinical development support and production of HCMV-TR3PP71 HIVGAG for clinical trials.</p> <p>Place of performance is Rockville, MD. The order is priced on a cost-plus-fixed-fee basis and has an ultimate completion date of July 31, 2019. No set-aside was used for this delivery order.</p>

<p>The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc. on September 26, 2014, with a ceiling value of $280,028.24 for preclinical development support including production of GEO-D02 master and working cell banks.</p> <p>Place of performance is Rockville, MD. The order carries an ultimate completion date of September 25, 2017. Pricing is Cost Plus Fixed Fee with no set-aside designation.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Becton, Dickinson and Company for $200,405.84 on March 1, 2024, for an 11-month service contract covering various equipment and lasers, with a completion date of January 31, 2025.</p> <p>Performance occurs in Bethesda, Maryland. The order is firm fixed price with no small business set-aside applied.</p>

The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc. on June 29, 2017, with a ceiling value of $8,677,861.82 for nonhuman primate purchase and holding under the HIV Microbicides and Biomedical Prevention 2016-2021 IDIQ. The order is priced on a cost-plus-fixed-fee basis with place of performance in Rockville, MD and an ultimate completion date of June 30, 2024. The parent IDIQ supports preclinical development services for...